Beyond Air, Inc. Foreign Currency Transaction Gain Loss After Tax
Beyond Air, Inc. (XAIR) reported Foreign Currency Transaction Gain Loss After Tax of -$3.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Income Statement › Other Income
us-gaap:ForeignCurrencyTransactionGainLossAfterTax · last filed 2026-08-13
- Beyond Air, Inc. foreign currency transaction gain loss after tax for the quarter ending 2026-06-30 was -$3.00K, a 102.34% decline year-over-year.
- Beyond Air, Inc. foreign currency transaction gain loss after tax for the quarter ending 2026-03-31 was -$27.00K.
- Beyond Air, Inc. foreign currency transaction gain loss after tax for the quarter ending 2025-06-30 was $128.00K.
- Beyond Air, Inc. foreign currency transaction gain loss after tax for fiscal 2026 was $119.00K.
| Period end | Foreign Currency Transaction Gain Loss After Tax 3 month | Foreign Currency Transaction Gain Loss After Tax 6 month | Foreign Currency Transaction Gain Loss After Tax 9 month | Foreign Currency Transaction Gain Loss After Tax 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$3.00K 10-Q · filed 2026-08-13 | -$30.00K derived: sum of 2 quarters · filed 2026-08-13 | ||
| 2026-03-31 | -$27.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-06-26 | $119.00K 10-K · filed 2026-06-26 | ||
| 2025-12-31 | $146.00K 10-Q · filed 2026-02-13 | |||
| 2025-06-30 | $128.00K 10-Q · filed 2026-08-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Tenon Medical, Inc. (TNON) | United States | $0.002B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Profusa, Inc. (PFSA) | United States | $0.002B | |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B |